CJ CheilJedang to Pursue Sale of Bio Business with Annual Sales of 4 Trillion Won
CJ CheilJedang is reportedly planning to sell its bio business division.
According to the investment banking (IB) industry on the 18th, CJ CheilJedang has selected Morgan Stanley as the lead advisor for the sale of its bio business division and is reportedly in contact with potential buyers.
CJ CheilJedang's bio division primarily focuses on the Green Bio business, which produces food seasoning materials and amino acids for animal feed.
The bio division of CJ CheilJedang recorded sales of 4.1343 trillion KRW last year, and has accumulated sales of 3.1474 trillion KRW up to the third quarter this year.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Industry insiders expect CJ CheilJedang to use the proceeds from the sale of its bio business to pursue mergers and acquisitions (M&A). The value of the bio business division is estimated to be in the trillions of KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
